PortfoliosLab logo

Pharmaron Beijing Co Ltd (3759.HK)

Equity · Currency in HKD · Last updated May 27, 2023

Company Info

ISINCNE100003PG4
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$57.75B
EPSHK$1.35
PE Ratio22.65
PEG RatioN/A
Revenue (TTM)HK$10.89B
Gross Profit (TTM)HK$2.68B
EBITDA (TTM)HK$2.35B
Year RangeHK$25.85 - HK$91.95
Target PriceHK$57.38

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in Pharmaron Beijing Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%December2023FebruaryMarchAprilMay
9.11%
31.45%
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 3759.HK

Pharmaron Beijing Co Ltd

Return

Pharmaron Beijing Co Ltd had a return of -43.95% year-to-date (YTD) and -46.29% in the last 12 months. Over the past 10 years, Pharmaron Beijing Co Ltd had an annualized return of 2.60%, while the S&P 500 had an annualized return of 8.37%, indicating that Pharmaron Beijing Co Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-10.34%-0.59%
Year-To-Date-43.95%7.47%
6 months-27.04%4.51%
1 year-46.29%-4.20%
5 years (annualized)2.60%8.37%
10 years (annualized)2.60%8.37%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20236.00%-23.52%-24.94%2.73%
2022-30.80%68.18%21.96%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Pharmaron Beijing Co Ltd (3759.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
3759.HK
Pharmaron Beijing Co Ltd
-0.67
^GSPC
S&P 500
0.27

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Pharmaron Beijing Co Ltd Sharpe ratio is -0.67. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20December2023FebruaryMarchAprilMay
-0.67
0.07
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

Dividend History

Pharmaron Beijing Co Ltd granted a 1.45% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.44 per share.


PeriodTTM202220212020
DividendHK$0.44HK$0.44HK$0.20HK$0.09

Dividend yield

1.45%0.81%0.26%0.10%

Monthly Dividends

The table displays the monthly dividend distributions for Pharmaron Beijing Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.44HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.20HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.09HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%December2023FebruaryMarchAprilMay
-77.89%
-12.22%
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Pharmaron Beijing Co Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Pharmaron Beijing Co Ltd is 80.77%, recorded on Oct 31, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.77%Jun 29, 2021331Oct 31, 2022
-37.47%Jan 26, 202129Mar 9, 202148May 20, 202177
-28.72%Feb 18, 202025Mar 23, 202020Apr 22, 202045
-23.25%Nov 6, 202017Nov 30, 202015Dec 21, 202032
-14.96%Aug 31, 20209Sep 10, 202020Oct 12, 202029

Volatility Chart

The current Pharmaron Beijing Co Ltd volatility is 15.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%December2023FebruaryMarchAprilMay
15.90%
4.15%
3759.HK (Pharmaron Beijing Co Ltd)
Benchmark (^GSPC)